Ex parte DEL BIANCO et al. - Page 3




          Appeal No. 1996-0756                                 Paper No. 24           
          Application No. 08/027,853                                 Page 3           
               The examiner found that unexpected results were                        
          demonstrated after six days of sequential                                   
          administration of both 10 IU/ml and                                         
          100 IU/ml                                                                   
          concentrations of IFN-                                                      
          $ followed by                                                               
          tamoxifen (an                                                               
          antiestrogen), but                                                          
          found no synergy at an                       IFN-$ concentration            
          of 1000 IU/ml, as                            illustrated in                 
          Appellants' Fig. 1B (right) (Paper No. 19 (Ex. Ans.) at 8).                 
          Indeed, after six days with an IFN-$ concentration of                       
          1000 IU/ml, there appears to be no difference between                       
          simultaneous (circles) and sequential (triangles) treatment.                
          Appellants point to no other data of record to support a                    
          finding of unexpected results.  We note that after three days               
          (Appellants' Fig. 1A, right), the claimed sequential                        
          administration (triangles) is less effective than simultaneous              
          treatment (circles) and, using a 10 IU/ml concentration of                  
          IFN-$, may be less effective than tamoxifen alone (the dotted               
          line "TAM").                                                                
               Evidence of nonobviousness must be commensurate in scope               
          with the claims that the evidence is offered to support.                    





Page:  Previous  1  2  3  4  5  Next 

Last modified: November 3, 2007